003017 大洋生物
已收盘 07-16 15:00:00
资讯
新帖
简况
股市必读：大洋生物（003017）7月15日董秘有最新回复
证券之星 · 07-16 02:23
股市必读：大洋生物（003017）7月15日董秘有最新回复
大洋生物：现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产
证券之星 · 07-15 08:40
大洋生物：现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产
大洋生物（003017）披露完成工商登记变更并换发营业执照公告，6月30日股价上涨7.03%
证券之星 · 06-30
大洋生物（003017）披露完成工商登记变更并换发营业执照公告，6月30日股价上涨7.03%
6月30日大洋生物涨7.03%，长城行业轮动混合A基金重仓该股
证券之星 · 06-30
6月30日大洋生物涨7.03%，长城行业轮动混合A基金重仓该股
大洋生物涨7.03%，开源证券二个月前给出“买入”评级
证券之星 · 06-30
大洋生物涨7.03%，开源证券二个月前给出“买入”评级
大洋生物（003017）披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告，6月26日股价上涨0.19%
证券之星 · 06-26
大洋生物（003017）披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告，6月26日股价上涨0.19%
大洋生物：现阶段相关产线正常生产，订单承接有序
证券之星 · 06-24
大洋生物：现阶段相关产线正常生产，订单承接有序
大洋生物：下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线
证券之星 · 06-24
大洋生物：下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线
大洋生物：山东大洋新材料子公司预计2026年8-9月开始投产
证券之星 · 06-24
大洋生物：山东大洋新材料子公司预计2026年8-9月开始投产
大洋生物：现阶段暂无进一步收购股权的相关计划
证券之星 · 06-24
大洋生物：现阶段暂无进一步收购股权的相关计划
大洋生物：除本公司与美国辉宝外全球暂未出现同等规模量产能力的第三方厂商
证券之星 · 06-24
大洋生物：除本公司与美国辉宝外全球暂未出现同等规模量产能力的第三方厂商
每周股票复盘：大洋生物（003017）拟每10股派3元转增2股
证券之星 · 06-21
每周股票复盘：大洋生物（003017）拟每10股派3元转增2股
大洋生物（003017）披露2025年年度利润分配及资本公积转增股本实施公告，6月18日股价下跌1.18%
证券之星 · 06-18
大洋生物（003017）披露2025年年度利润分配及资本公积转增股本实施公告，6月18日股价下跌1.18%
大洋生物：项目尚处于前期筹备中
证券之星 · 05-28
大洋生物：项目尚处于前期筹备中
大洋生物：目前公司碳酸钾产品主要以农药、医药、陶瓷、玻璃制造等通用型工业领域应用为主
证券之星 · 05-28
大洋生物：目前公司碳酸钾产品主要以农药、医药、陶瓷、玻璃制造等通用型工业领域应用为主
股市必读：大洋生物（003017）5月21日收盘跌5.03%，主力净流出1267.65万元
证券之星 · 05-22
股市必读：大洋生物（003017）5月21日收盘跌5.03%，主力净流出1267.65万元
大洋生物（003017）披露实际控制人一致行动人减持股份预披露公告，5月20日股价上涨0.16%
证券之星 · 05-20
大洋生物（003017）披露实际控制人一致行动人减持股份预披露公告，5月20日股价上涨0.16%
大洋生物（003017）披露2025年年度股东会决议公告，5月19日股价下跌2.2%
证券之星 · 05-19
大洋生物（003017）披露2025年年度股东会决议公告，5月19日股价下跌2.2%
每周股票复盘：大洋生物（003017）Q1营收增11.71%
证券之星 · 05-03
每周股票复盘：大洋生物（003017）Q1营收增11.71%
大洋生物：芯之纯生产的高纯陶瓷材料属于半导体设备耗材
证券之星 · 04-30
大洋生物：芯之纯生产的高纯陶瓷材料属于半导体设备耗材
加载更多
公司概况
公司名称：
浙江大洋生物科技集团股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2020-10-26
主营业务：
浙江大洋生物科技集团股份有限公司的主营业务是基础化学原料制造和销售、化学产品制造和销售。公司的主要产品是无机盐产品、精细化工产品。公司是国家级专精特新“小巨人”。
发行价格：
28.85
{"stockData":{"symbol":"003017","market":"SZ","secType":"STK","nameCN":"大洋生物","latestPrice":21.82,"timestamp":1784185395000,"preClose":21.86,"halted":0,"volume":1347061,"delay":0,"changeRate":-0.0018,"floatShares":83145600,"shares":101000000,"eps":1.0058,"marketStatus":"已收盘","change":-0.04,"latestTime":"07-16 15:00:00","open":21.61,"high":22.14,"low":21.55,"amount":29483500,"amplitude":0.027,"askPrice":21.82,"askSize":114,"bidPrice":21.8,"bidSize":16,"shortable":0,"etf":0,"ttmEps":1.0058,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784251800000},"marketStatusCode":5,"adr":0,"adjPreClose":21.86,"symbolType":"stock","openAndCloseTimeList":[[1784165400000,1784172600000],[1784178000000,1784185200000]],"highLimit":24.05,"lowLimit":19.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":100800000,"isCdr":false,"pbRate":1.89,"roa":"--","peRate":21.694174,"roe":"2.68%","epsLYR":1.2257,"committee":-0.441595,"marketValue":2199000000,"turnoverRate":0.0162,"status":1,"floatMarketCap":1814000000},"requestUrl":"/m/hq/s/003017","defaultTab":"news","newsList":[{"id":"2651989684","title":"股市必读：大洋生物（003017）7月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651989684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651989684?lang=zh_cn&edition=full","pubTime":"2026-07-16 02:23","pubTimestamp":1784139788,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，大洋生物报收于21.86元，下跌0.36%，换手率1.87%，成交量1.56万手，成交额3405.07万元。针对氯化钾等原材料成本波动，公司结合行业供需、下游客户采购规模及市场竞争格局调整碳酸钾售价，通过灵活定价机制对冲成本压力。公司已于2026年6月26日完成2025年年度权益分派实施，后续若推出新的规划，将及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600002242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651806414","title":"大洋生物：现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2651806414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651806414?lang=zh_cn&edition=full","pubTime":"2026-07-15 08:40","pubTimestamp":1784076020,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，6-9月国内禽类、水产养殖进入传统旺季，全球仅公司与辉宝两家盐酸氨丙啉供应商，以色列工厂地缘风险持续扰动供给： 1.当前600吨老产线是否维持满产，海外客户订单排单到几月，三季度产品售价是否存在上调空间？公司现有年产600吨盐酸氨丙啉生产线维持满负荷连续生产，海外客户订单承接有序。公司年产800吨盐酸氨丙啉技改搬迁项目启动试产后，原有600吨老产线将结合监管要求与整体生产规划有序关停。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500009782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343715","title":"大洋生物（003017）披露完成工商登记变更并换发营业执照公告，6月30日股价上涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647343715?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:53","pubTimestamp":1782813184,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，大洋生物报收于23.0元，较前一交易日上涨7.03%，最新总市值为23.18亿元。近日，大洋生物披露《关于完成工商登记变更并换发营业执照的公告》。公告显示，公司于2026年4月24日召开第六届董事会第九次会议，并于2026年5月18日召开2025年年度股东会，审议通过了关于变更注册资本、经营范围并修订《公司章程》的议案。公司已完成工商变更登记及《公司章程》备案手续，并取得浙江省市场监督管理局核发的新营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536272","title":"6月30日大洋生物涨7.03%，长城行业轮动混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647536272?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:50","pubTimestamp":1782809430,"startTime":"0","endTime":"0","summary":"证券之星消息，6月30日大洋生物涨7.03%，收盘报23.0元，换手率5.47%，成交量4.55万手，成交额1.02亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为长城基金的长城行业轮动混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000030381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536204","title":"大洋生物涨7.03%，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536204","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647536204?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:50","pubTimestamp":1782809421,"startTime":"0","endTime":"0","summary":"今日大洋生物涨7.03%，收盘报23.0元。2026年4月28日，开源证券研究员金益腾,蒋跨跃发布了对大洋生物的研报《公司信息更新报告：Q1业绩同环比增长，产业链布局逐步完善》，该研报对大洋生物给出“买入”评级。研报中预计2026-2028年归母净利润为1.67、2.21、2.42亿元，EPS为1.99、2.63、2.88元，当前股价对应PE为16.0、12.2、11.1倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为开源证券的蒋跨跃、金益腾。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000030377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646077365","title":"大洋生物（003017）披露使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告，6月26日股价上涨0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646077365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646077365?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:49","pubTimestamp":1782485353,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，大洋生物报收于21.63元，较前一交易日上涨0.19%，最新总市值为21.8亿元。该股当日开盘21.73元，最高22.22元，最低21.22元，成交额达4852万元，换手率为2.69%。近日，浙江大洋生物科技集团股份有限公司发布《关于使用部分闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告》。公司使用闲置募集资金进行现金管理不影响募投项目建设，未超出董事会授权额度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600046022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645309893","title":"大洋生物：现阶段相关产线正常生产，订单承接有序","url":"https://stock-news.laohu8.com/highlight/detail?id=2645309893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645309893?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:03","pubTimestamp":1782288196,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，全球盐酸氨丙啉仅两家供应，海外同行产能受限，想请教：1、2026年二季度盐酸氨丙啉新增海外订单同比是否明显增长？2、现有产线已满负荷生产的情况下，目前在手订单交付排期有多久？麻烦介绍下当前产能释放与订单承接情况，感谢！大洋生物回复：您好，感谢您对公司的关注。2026年第二季度的情况请关注公司披露的定期报告。现阶段相关产线正常生产，订单承接有序。待年产800吨搬迁扩建技改项目投产后，产能及交付能力会有所改善。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400026798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645933768","title":"大洋生物：下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线","url":"https://stock-news.laohu8.com/highlight/detail?id=2645933768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645933768?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:00","pubTimestamp":1782288046,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：据悉，鉴于目前盐酸氨丙啉供应局势，公司会综合考虑在下王工厂投产时，是否关闭现有600吨产能？大洋生物回复：您好，感谢您的关注。公司下王年产800吨盐酸氨丙啉技改搬迁扩建项目投产后，将按计划逐步关停现有600吨/年生产线，产线关停的具体实施节奏与时间节点将结合项目投产进度及行业监管相关要求推进。敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400026521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889337","title":"大洋生物：山东大洋新材料子公司预计2026年8-9月开始投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645889337?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:00","pubTimestamp":1782288044,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：山东大洋开始大量招聘操作工了，一期3万吨轻质预计什么时候投产大洋生物回复：您好，感谢您的关注。山东大洋新材料子公司预计2026年8-9月开始投产。实际投产日期受多重因素影响，敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400026517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","159703","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645981898","title":"大洋生物：现阶段暂无进一步收购股权的相关计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2645981898","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645981898?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:39","pubTimestamp":1782286753,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问大洋生物有没有，后续收购、芯之纯半导体材料公司剩余股权的口头协议，或者书面协议呢？或者公司是计划赶在芯之纯产品量产的时候再收购吗？大洋生物回复：您好，感谢您的关注。公司目前持有芯之纯半导体材料有限公司30%股权，本次投资以战略投资为主，现阶段暂无进一步收购股权的相关计划。公司将持续跟踪芯之纯日常经营与业务发展动态，未来如涉及股权收购等重大事项，公司将严格按照监管规则及时履行信息披露义务。敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400023232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645905898","title":"大洋生物：除本公司与美国辉宝外全球暂未出现同等规模量产能力的第三方厂商","url":"https://stock-news.laohu8.com/highlight/detail?id=2645905898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645905898?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:39","pubTimestamp":1782286749,"startTime":"0","endTime":"0","summary":"投资者提问：董秘您好，公司800吨盐酸氨丙啉技改项目即将投产，想了解行业供给情况：1、除公司与辉宝以外，全球是否还有其他具备同等交付能力的产能？辉宝工厂长期停产是否造成全球有效供给大幅收缩？除本公司与美国辉宝外，全球市场上目前暂未出现具备同等规模量产能力、稳定供货记录及完备合规资质的第三方厂商。部分企业虽有小规模量产规划或实验级产能，但与公司及辉宝在有效产能、批量交付能力上存在明显差距。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400023221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645709601","title":"每周股票复盘：大洋生物（003017）拟每10股派3元转增2股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645709601","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645709601?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:40","pubTimestamp":1781984422,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，大洋生物报收于26.0元，较上周的26.74元下跌2.77%。本周，大洋生物6月15日盘中最高价报27.38元。公司公告汇总浙江大洋生物科技集团股份有限公司2025年年度权益分派方案为：以总股本84,000,000股为基数，向全体股东每10股派发现金红利3.00元（含税），同时以资本公积金每10股转增2股。本次权益分派股权登记日为2026年6月25日，除权除息日为2026年6月26日。分红前总股本为84,000,000股，分红后总股本增至100,800,000股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644704811","title":"大洋生物（003017）披露2025年年度利润分配及资本公积转增股本实施公告，6月18日股价下跌1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644704811","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644704811?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:40","pubTimestamp":1781775641,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，大洋生物报收于26.0元，较前一交易日下跌1.18%，最新总市值为21.84亿元。该股当日开盘26.21元，最高26.42元，最低25.88元，成交额达3338.24万元，换手率为1.85%。大洋生物于2026年6月18日披露《2025年年度利润分配及资本公积转增股本实施公告》。公告显示，公司2025年年度权益分派方案为：以总股本84,000,000股为基数，向全体股东每10股派发现金红利3.00元（含税），同时以资本公积金每10股转增2股。分红前总股本为84,000,000股，分红后总股本增至100,800,000股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800031520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638133668","title":"大洋生物：项目尚处于前期筹备中","url":"https://stock-news.laohu8.com/highlight/detail?id=2638133668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638133668?lang=zh_cn&edition=full","pubTime":"2026-05-28 15:27","pubTimestamp":1779953228,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)05月28日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在今年一月股东大会上通过了建设PEEK和中间体项目，请问该项目目前的进展情况和未来的进度？大洋生物回复：尊敬的投资者，您好！公司拥有PEEK中间体氟酮生产的中试技术，以及氟酮关键原料氟苯的生产产能。作为化工原料/材料生产项目，前期涉及的许可与备案手续耗时较长，项目尚处于前期筹备中。敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800022231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638366890","title":"大洋生物：目前公司碳酸钾产品主要以农药、医药、陶瓷、玻璃制造等通用型工业领域应用为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2638366890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638366890?lang=zh_cn&edition=full","pubTime":"2026-05-28 15:27","pubTimestamp":1779953227,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)05月28日在投资者关系平台上答复投资者关心的问题。投资者提问：做为国内碳酸钾龙头企业，请问公司有没有电子级碳酸钾产品？如果目前没有，是否正在研发或有计划研发？大洋生物回复：尊敬的投资者，您好！目前公司碳酸钾产品主要以农药、医药、陶瓷、玻璃制造等通用型工业领域应用为主，尚未有电子级碳酸钾产品在售。公司回密切关注市场需求动态及行业技术发展趋势，敬请投资者注意投资风险。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800022230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1161","09939","159938","BK0229","003017","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637356408","title":"股市必读：大洋生物（003017）5月21日收盘跌5.03%，主力净流出1267.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637356408","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637356408?lang=zh_cn&edition=full","pubTime":"2026-05-22 02:33","pubTimestamp":1779388390,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，大洋生物报收于29.66元，下跌5.03%，换手率5.72%，成交量3.96万手，成交额1.21亿元。当日关注点来自交易信息汇总：大洋生物股价连续3日下跌，5月21日收盘报29.66元，跌5.03%，当日成交396.1万元。该股最近90天内共有1家机构给出评级，买入评级1家。资金流向5月21日主力资金净流出1267.65万元；游资资金净流入688.9万元；散户资金净流入578.75万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200003079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636084320","title":"大洋生物（003017）披露实际控制人一致行动人减持股份预披露公告，5月20日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636084320","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636084320?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:10","pubTimestamp":1779271822,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，大洋生物报收于31.23元，较前一交易日上涨0.16%，最新总市值为26.23亿元。近日，大洋生物发布《关于实际控制人的一致行动人减持股份的预披露公告》。公告显示，公司实际控制人陈阳贵的一致行动人钱建春、陈寿良、赵玉梅拟自2026年6月10日起至2026年9月9日止，通过集中竞价方式减持公司股份合计不超过534,723股，占公司总股本的0.63%。截至公告日，相关股东均履行了此前承诺，不存在不得减持情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636883284","title":"大洋生物（003017）披露2025年年度股东会决议公告，5月19日股价下跌2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636883284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636883284?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:40","pubTimestamp":1779183633,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，大洋生物报收于31.18元，较前一交易日下跌2.2%，最新总市值为26.19亿元。该股当日开盘32.08元，最高32.12元，最低30.86元，成交额达1.35亿元，换手率为6.23%。大洋生物于近日披露《浙江大洋生物科技集团股份有限公司2025年年度股东会决议公告》。会议表决结果均为通过，中小投资者对部分议案存在反对票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900033990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632367269","title":"每周股票复盘：大洋生物（003017）Q1营收增11.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632367269","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632367269?lang=zh_cn&edition=full","pubTime":"2026-05-03 04:22","pubTimestamp":1777753332,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，大洋生物报收于32.12元，较上周的31.52元上涨1.9%。本周，大洋生物4月27日盘中最高价报32.43元。本周关注点来自业绩披露要点：大洋生物2026年一季报显示，一季度主营收入2.78亿元，同比上升11.71%。股本股东变化股东户数变动截至2026年3月31日，大洋生物股东户数为1.21万户，较12月31日增加431.0户，增幅3.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631570060","title":"大洋生物：芯之纯生产的高纯陶瓷材料属于半导体设备耗材","url":"https://stock-news.laohu8.com/highlight/detail?id=2631570060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631570060?lang=zh_cn&edition=full","pubTime":"2026-04-30 11:36","pubTimestamp":1777520201,"startTime":"0","endTime":"0","summary":"证券之星消息，大洋生物(003017)04月29日在投资者关系平台上答复投资者关心的问题。投资者提问：浙江芯之纯的半导体陶瓷零部件属于消耗品吗？预计什么时候能通过验证？大洋生物回复：尊敬的投资者，您好！芯之纯生产的高纯陶瓷材料属于半导体设备耗材，产品验证周期较长，目前尚在客户验证过程中。敬请投资者注意投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000039286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","159582","003017"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784232919409,"stockEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0132},{"period":"3month","weight":-0.1417},{"period":"6month","weight":-0.1759},{"period":"1year","weight":-0.0304},{"period":"ytd","weight":-0.1129}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.0417},{"period":"6month","weight":-0.0535},{"period":"1year","weight":0.1081},{"period":"ytd","weight":-0.0218}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江大洋生物科技集团股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"12064人(较上一季度减少92.20%)","perCapita":"6892股","listingDate":"2020-10-26","address":"浙江省杭州市建德市大洋镇朝阳路22号","registeredCapital":"10080万元","survey":" 浙江大洋生物科技集团股份有限公司的主营业务是基础化学原料制造和销售、化学产品制造和销售。公司的主要产品是无机盐产品、精细化工产品。公司是国家级专精特新“小巨人”。","listedPrice":28.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大洋生物,003017,大洋生物股票,大洋生物股票老虎,大洋生物股票老虎国际,大洋生物行情,大洋生物股票行情,大洋生物股价,大洋生物股市,大洋生物股票价格,大洋生物股票交易,大洋生物股票购买,大洋生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}